Home > Drug Search >
  • company_query: Adimab
  •   > 
Drug Filter
Category:
chemistry (7) biology (9)
Status:
Approved (1) Phase Ⅲ (1) Phase Ⅱ (8) Phase Ⅰ (6)
Clinical Stage:
Pending (1) Active (11) Discontinued (3)
Bio-Type:
Gene therapy (1) Cell therapy (3) Oncolytic virus (1) Vaccine (1) Bispecific antibody (1) Other recombinant protein (1) Fusion protein (1)
Indication:
Acute myeloid Leukemia (AML) (1) Bladder cancer (1) Breast cancer (1) HIV infection (1) Malignancies (1) Melanoma (2) Myelodysplastic syndrome (MDS) (1) Ovarian cancer (1) Pancreatic cancer (2) Prostate cancer (2) Small cell lung cancer (SCLC) (1) Solid tumours (2) Nasopharyngeal cancer (1) Tropical spastic paraparesis (1) Stroke (1) Diagnostic agents (1) Kaposi's sarcoma (2) Renal carcinoma (1) Ischemia-reperfusion injury (1) Mesothelioma (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top